Exploring clinical pathways to a metastatic lung cancer diagnosis: A latent class analysis using North Carolina multi-payer claims data
Interventions tailored to utilization patterns-particularly for low-contact and emergency-based care users-may improve diagnostic equity, biomarker testing, and outcomes.
Authors
- Lorinda A. Coombs (ORCID: https://orcid.org/0000-0003-1096-8974)
- Caroline A. Thompson (ORCID: https://orcid.org/0000-0001-9990-9756)
- K. Reeder-Hayes
- J. Weiss
- Xi Zhou
- Fernando Diaz
- Jennifer L. Lund
Institutions
- University of North Carolina at Chapel Hill (US)
- University of North Carolina Health Care (US)
- San Diego State University (US)
- The US Oncology Network (US)
Publication Details
- Journal
- Cancer Epidemiology Biomarkers & Prevention
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1158/1055-9965.epi-25-1859
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00